光子嫩肤技术联合复方黄柏液治疗面部激素依赖性皮炎患者的效果

摘要
图/表
参考文献(20)
相关文章 (0)

全文: PDF (623 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨光子嫩肤技术联合复方黄柏液治疗面部激素依赖性皮炎（FCAD）患者的效果。方法选取2015年6月～2017年5月广东省高州市人民医院皮肤科确诊的FCAD患者96例，按照随机数字表法分为三组，每组各32例。黄柏组外用他克莫司软膏＋复方黄柏液湿敷，光子组外用他克莫司软膏＋光子嫩肤仪，联合组外用他克莫司软膏＋复方黄柏液湿敷＋光子嫩肤技术，疗程均为8周。比较三组患者治疗后皮肤屏障功能指标[经皮水分丢失（TEWL）值、表皮含水量、表皮油脂含量]、治疗前后皮肤病生活质量指标（DLQI）得分以及疗效，记录并比较三组患者治疗期间不良反应情况及疗程结束后8周内复发情况。结果治疗后三组患者皮肤屏障功能指标、DLQI得分以及总有效率比较差异均有统计学意义（P ＜ 0.05）。治疗后联合组TEWL值低于光子组和黄柏组，光子组低于黄柏组，差异均有统计学意义（P ＜ 0.05）；治疗后联合组表皮含水量、表皮油脂含量、总有效率均高于光子组和黄柏组，光子组高于黄柏组，而联合组DLQI得分低于光子组和黄柏组，光子组低于黄柏组，差异均有统计学意义（P ＜ 0.05）。治疗期间三组不良反应发生率比较差异无统计学意义（P ＞ 0.05），且疗程结束后8周内均无复发情况。结论光子嫩肤技术联合复方黄柏液及他克莫司软膏治疗FCAD效果显著，并且可显著改善患者皮肤屏障功能，提高患者生活质量，安全性高，值得临床推广。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	苏春志黎超伟曾洲平

关键词 ：光子嫩肤技术, 复方黄柏液, 面部激素依赖性皮炎

Abstract：Objective To explore the effect of photon rejuvenation technology combined with Compound Cortex Phellodendri Liquid in the treatment of patients with facial corticosteroid addictive dermatitis (FCAD). Methods Ninety-six cases of patients diagnosed as FCAD in Department of Dermatology, Gaozhou People's Hospital from June 2015 to May 2017 were randomly divided into 3 groups, with 32 patients in each group. The Cortex Phellodendri group was treated with Compound Cortex Phellodendri Liquid combined with Tacrolimus Ointment. The photon group was treated with Tacrolimus Ointment combined with photon rejuvenation technology. The combination group was treated with photon rejuvenation technology combined with tacrolimus ointment and Compound Cortex Phellodendri Liquid. The course of treatment was 8 weeks. Skin barrier function indices [transepidermal water loss (TEWL), the moisture and oil contents of skin], the therapeutic effect after treatment and the scores of dermatology life quality index (DLQI) before and after treatment were compared among the 3 groups. The therapeutic effects after treatment of the 3 groups were compared. The adverse reactions during treatment and relapse situation after treatment with a 8-week follow-up were recorded and compared. Results There were significant differences in the values of skin barrier function indices, the scores of DLQI and the therapeutic effect after treatment among the 3 groups (P ＜ 0.05). After treatment, TEWL score of the combination group was lower than the photon group and Cortex Phellodendri group, while the photon group was lower than the Cortex Phellodendri group (P ＜ 0.05). Moisture and oil contents of skin, the therapeutic effect distribution after treatment of the combination group were higher than the photon group and Cortex Phellodendri group, while the photon group was higher than the Cortex Phellodendri group, while the scores of DLQI of the combination group were lower than the photon group and Cortex Phellodendri group, which of photon group were lower than those of Cortex Phellodendri group (P ＜ 0.05). There were no statistically significant differences of adverse reactions among three groups (P ＞ 0.05). There was no recurrence situation in a 8-week follow-up after treatment among three groups. Conclusion The photon rejuvenation technology combined with Tacrolimus Ointment and Compound Cortex Phellodendri Liquid in the treatment of FCAD has obvious effect, which can significantly improve the skin barrier function and the quality of life. The treatment is safe and worth of clinical promotion.

Key words： Photon rejuvenation technology Compound Cortex Phellodendri Liquid Facial corticosteroid addictive dermatitis

引用本文:

苏春志黎超伟曾洲平 . 光子嫩肤技术联合复方黄柏液治疗面部激素依赖性皮炎患者的效果[J]. 中国医药导报, 2018, 15(14): 107-110.
SU Chunzhi LI Chaowei ZENG Zhouping. Effect of photon rejuvenation technology combined with Compound Cortex Phellodendri Liquid in the treatment of patients with facial corticosteroid addictive dermatitis. 中国医药导报, 2018, 15(14): 107-110.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2018/V15/I14/107

[1] 赵婵.激素依赖性皮炎的诊断与外治疗法[J].长春中医药大学学报，2015，31（6）：1274-1276.
[2] 张玲.皮炎冲剂治疗血热型面部激素依赖性皮炎的临床研究[J].世界中西医结合杂志，2017，12（8）：100-103.
[3] 沈芳，谢韶琼，宋勋，等.复方黄柏液联合糖皮质激素乳膏治疗急性湿疹60例临床观察[J].中国皮肤性病学杂志，2015，29（12）：1314-1316.
[4] Kim BK，Lee NR，Park SY，et al. Efficacy of photodynamic therapy with laser pretreatment for actinic keratosis and photorejuvenation as evaluated by fluorescent imaging [J]. Photodermatol Photoimmunol Photomed，2015，31（1）：36-43.
[5] 孙文兰，魏烨平，于腾阳，等.综合疗法治疗面部激素依赖性皮炎的疗效观察[J].华南国防医学杂志，2015，29（5）：398-399.
[6] Finlay AY，Basra MK，Piguet V，et al. Dermatology life quality index（DLQI）：a paradigm shift to patient-centered outcomes [J]. J Invest Dermatol，2012，132（10）：2464-2465.
[7] 何雪冬.加味知柏地黄汤联合他克莫司软膏对阴虚内热型糖皮质激素依赖性皮炎患者皮肤屏障功能的影响[J].环球中医药，2017，10（1）：100-102.
[8] 范向华，施健，缪旭. 朗格汉斯细胞在初发及复发尖锐湿疣皮损中的形态学变化[J].中国皮肤性病学杂志，2016， 30（8）：787-789.
[9] Momota Y，Shimada K，Gin A，et al. Measurement of transepidermal water loss（TEWL） in cats with experimental skin barrier dysfunction using a closed chamber system [J]. Vet Dermatol，2016，27（5）：428-431.
[10] 李云珠，路雪艳，姜薇，等.青鹏软膏对皮肤干燥志愿者及特应性皮炎样小鼠模型皮肤屏障功能的影响[J].中华皮肤科杂志，2016，49（1）：43-47.
[11] 张辉，史龙强.他克莫司联合复方倍他米松对激素依赖性皮炎患者皮损评分及表皮含水量的影响[J].西部医学，2016，28（7）：987-990.
[12] D?觟lle S，Hielscher N，Bareille PJ，et al. Clinical efficacy and tolerability of a novel selective corticosteroid in atopic dermatitis-two randomised controlled trials [J]. Skin Pharmacol Physiol，2015，28（3）：159-166.
[13] 李卫民，倪红.他克莫司软膏治疗面部糖皮质激素依赖性皮炎临床疗效观察[J].解放军医学杂志，2015，40（8）：686-686.
[14] 潘勇华，蒋红，陈井霞，等.复方黄柏液处方优化及体外经皮渗透效果的研究[J].药学服务与研究，2017，17（5）：411-414.
[15] Martella A，Raichi M. Photo-epilation and Skin Photorejuvenation：An Update [J]. Dermat Rep，2017，9（1）：9-13.
[16] 徐永康.光子嫩肤在皮肤美容中的应用疗效[J].中国公共卫生，2015，22（3）：19-20.
[17] 赵俊英.强脉冲光治疗面部激素依赖性皮炎临床研究[J].中国麻风皮肤病杂志，2017，33（4）：229-230.
[18] 常杰平，冯秀凤，刘菁，等.光子嫩肤技术与微波治疗皮肤毛细血管扩张患者的临床疗效比较[J].实用临床医药杂志，2014，18（11）：100-101.
[19] 张莲，唐承伟，张爱华，等.126例面部糖皮质激素依赖性皮炎患者心理状况和生活质量调查分析[J].解放军预防医学杂志，2017，35（10）：123-125.
[20] 顾煜，李伟，海日古力·克比尔，等.复方黄柏液联合派瑞松治疗脂溢性皮炎的临床研究[J].现代生物医学进展，2016，16（12）：2284-2286.